The focus of this presentation is on Human Herpes Virus infections/reactivation and related lymphoid proliferations and does not include post-transplant or iatrogenic Epstein Barr virus (EBV)-associated lymphoproliferative disorders.
BamA rightward transcript (BART) RNAs with no expression of protein coding transcript, also known as latency 0, which allows the virus to evade the immune system.
Reactivation can be non-productive with the additional expression of up to 6 nuclear antigens (EBNAs) and a number of membrane proteins (LMP-1, LMP-2 and vBCL-2).
The full range of latent gene expression, latency type III, can be observed in tonsillar B cells during acute infection manifesting clinically as acute infectious mononucleosis (AIM), in post transplant lymphoproliferative disorders (PTLD), and in lymphoblastoid cells lines. Other forms of latency in between latency type 0 and III, namely type I and type II, are usually associated with EBV-associated malignancies, both lymphoid and epithelial. (1) Usually primary infection is asymptomatic and occurs early in life or childhood, and when symptomatic is usually a self-limited disease occurring in adolescent or young adults (acute infectious mononucleosis, AIM). About half of the patients with AIM present with the triad of fever, lymphadenopathy, and pharyngitis and in another 10%, splenomegaly, hepatomegaly, and palatal petechiae may occur. Less common complications include hemolytic anemia, thrombocytopenia, aplastic anemia, myocarditis, hepatitis, genital ulcer, splenic rupture, rash, and neurologic complications (2) . Most patients will have leukocytosis with an increased number of mononuclear cells.
The atypical lymphocytes in the peripheral blood smear are primary T-cells, that are responding to EBV-positive B cells (Downey type II). (2) As mentioned, the predominant target of the latent viral infection is the resting memory B-cell, although some in vitro studies have shown that EBV can also infect naïve B cells.
Based on recent studies on purified B-cell subsets from AIM and chronic seropositive donors using peripheral blood as well as tonsillar biopsies, besides quantitative differences of the viral load, there were also differences in the predominant subsets of This hypothesis is also supported by the pattern of involvement by EBV infected B cells, which has been described in reactive tonsils as well as during the course of AIM (4, 5) . A large number of EBER positive cells with a subset expressing EBNA-2 and LMP1, latency type III, is found predominantly in the interfollicular areas without involvement of germinal centers; these cells are also often CD30 positive and correspond to activated immunoblasts.
The histological features of tonsils or lymph nodes in patients with AIM can vary greatly, In the subsequent larger series (12), the overall survival was poor in both polymorphic and monomorphic groups and inferior to EBV-negative diffuse large cell lymphoma. This led to inclusion in the WHO classification (2008)(9) of "EBV positive DLBCL of the elderly". In reviewing our cases of age-related EBV LPDs, we identified a subset of patients with localized extranodal disease, manifesting as mucocutaneous ulcer (13) In our experience, the pathological spectrum of age-related LPD is broader than that previously reported by Oyama et al (12) . In order to recognize these cases, it is important to perform in situ hybridization for EBV, since some of the early lesions may be easily We have described two cases of viral HHV6 lymphadenitis occurring in immunocompetent hosts and presenting as an acute viral illness (22) . Histologically, the lymph nodes show marked paracortical expansion due to a proliferation of CD4-positve T-cells with nuclear and cytoplasmic inclusions, as shown by the strong positivity with an antibody against the envelope glycoprotein gp60/110kDa. The presence of the virus was also confirmed by electron microscopy and molecular studies.
